Mintz announced today that 42 of its practices and 83 of its attorneys earned recognition in the 2024 edition of Chambers USA, a guide to the country’s leading law firms. Of those included in the guide, 18 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm obtained new listings in three practice areas and 10 of its lawyers were recognized for the first time.

CAMBRIDGE, Mass.—Mintz advised Quaise Energy, a developer of a new hybrid deep drilling technology for geothermal energy, in its recent $21 million Series A1 funding round. The deal brings Quaise’s total funding to more than $95 million. The investment will be used to scale up Quaise’s supply chain and enhance its field operations by improving geologic understanding at plant sites.

Bloomberg Law quoted Members Joshua Fox and Louis Mercedes, as well as Associate Aaron Fenton in an article analyzing potential reasons why Harvard Law graduates are accepting job offers outside of Massachusetts. Joshua, Lou, and Aaron discussed the benefits graduates have when staying local to the Boston area.

BOSTON – Mintz announced today that it advised Hopewell Therapeutics, a biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry, in its Seed Financing of up to $25 million. The funds will enable Hopewell to advance the development of genomic medicines based on its differentiated tissue-targeted Lipid Nanoparticle (ttLNP) platform through both internal pipeline programs and external partnerships.

BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.

Carta quoted Member Joshua Fox about the state of the venture capital environment and the creative solutions startups are leaning on to avoid a down round.

Mintz's sponsorship and involvement with the MassNextGen Initiative was highlighted in a press release issued by the Massachusetts Life Sciences Center.

BOSTON – Mintz has entered into an exclusive partnership with Nucleate Boston, providing the nonprofit organization with legal support for its 2023 Activator Program.

Mintz Member Joshua Fox spoke to the Wall Street Journal about what's ahead for biotech startups and venture capitalists following a difficult year.

Mintz Member Joshua Fox spoke to Forbes about the logistics of Shark Tank and how deal terms develop after filming.

Mintz advised Asimov in a $200 million fundraising aimed at helping the synthetic biology company scale its tools and services business focused on biologics, cell and gene therapies, and RNA. Mintz Member and seasoned life sciences transactional attorney Joshua Fox led a team that included Associates Kaoru Suzuki and Michael Katz.

Mintz represented Axoft, a neurotechnology company, in its $8 million seed round led by The Engine, a venture firm spun out of MIT that invests in early-stage Tough Tech companies.

Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.